Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?
The greater the risk of a disease, the greater the risk doctors would be prepared to take to prevent it.
Full Article
Does the AstraZeneca vaccine still pass the risk-benefit analysis for young people?
Sky News
0 shares
1 views
- More about:
AstraZeneca
You might like
Related news coverage
Moderna vaccine 'may be reserved for young people' amid AstraZeneca risk
The EMA and the MHRA have both carried out reviews into reports of rare brain clots in people who have had the AstraZeneca vaccine
Tamworth Herald
Young people most at risk of rare blood clots after AstraZeneca vaccine
Younger adults are most at risk of rare blood clotting after having the Oxford-AstraZeneca vaccine, the UK’s medicines regulator..
The Argus